发明名称 NOVEL MODIFIED RELEASED FORMULATION
摘要 The present invention is directed to a multiparticulate, modified release solid dispersion formulation, comprising a drug substance having a pH-dependent solubility, said drug substance being a compound of the formula I, or a pharmaceutically acceptable salt thereof; a hydrophobic matrix former which is a water-insoluble, non-swelling amphiphilic lipid; and a hydrophilic matrix former which is a meltable, water-soluble excipient; wherein the weight ratio hydrophobic matrix former/hydrophilic matrix former is >=1; and the particle size is less than 300 mum. Also a unit dosage of the same, as well as a process for the preparation thereof and the use of the formulation and unit dosage is claimed.
申请公布号 KR20040058103(A) 申请公布日期 2004.07.03
申请号 KR20037010577 申请日期 2003.08.12
申请人 发明人
分类号 A61K9/22;C07D211/90;A61K9/10;A61K9/14;A61K9/16;A61K9/20;A61K9/26;A61K9/52;A61K31/277;A61K31/437;A61K31/4422;A61K45/00;A61K47/10;A61K47/12;A61K47/14;A61K47/34;A61K47/38;A61K47/44;A61P1/04;A61P9/00;A61P9/08;A61P9/12;A61P35/00;C07D471/04 主分类号 A61K9/22
代理机构 代理人
主权项
地址